ConductScience.org, home

Paper42017162

Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, docking-guided optimization and apoptotic profiling.

Jauhari A and 6 others. RSC Adv, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, docking-guided optimization and apoptotic profiling. Papers, record 42017162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42017162

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of thieno[3,2-c]pyran-based leads for liver, lung and glioma cancer: synthesis, docking-guided optimization and apoptotic profiling.
PubMed
Journal
RSC Adv
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jauhari AAbhishek
2Pooja
3Taneja LLakshay
4Yadav AKAjay Kumar
5Althagafi IIsmail
6Pratap RRamendrahttps://orcid.org/0000-0003-1846-1561
7Yadav DKDharmendra Kumarhttps://orcid.org/0000-0003-1102-1993

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126301627Chromanyl-isoxazolidines as Antibacterial agents: Synthesis, Biological Evaluation, Quantitative Structure Activity Relationship, and Molecular Docking Studies.Chem Biol Drug Des2016https://conductscience.org/library/papers/26301627PubMed
22432605Expression of a multidrug-resistance gene in human tumors and tissues.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/2432605PubMed
338474579Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives.Molecules2024https://conductscience.org/library/papers/38474579PubMed
418257542Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells.J Med Chem2008https://conductscience.org/library/papers/18257542PubMed
528084588Regulation of miR-34 Family in Neuronal Development.Mol Neurobiol2018https://conductscience.org/library/papers/28084588PubMed
630620402Cancer statistics, 2019.CA Cancer J Clin2019https://conductscience.org/library/papers/30620402PubMed
724047270Chromenes: potential new chemotherapeutic agents for cancer.Future Med Chem2013https://conductscience.org/library/papers/24047270PubMed
839585598Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells.J Neurooncol2025https://conductscience.org/library/papers/39585598PubMed
926742998Cancer statistics, 2016.CA Cancer J Clin2016https://conductscience.org/library/papers/26742998PubMed
1016110319The concept of synthetic lethality in the context of anticancer therapy.Nat Rev Cancer2005https://conductscience.org/library/papers/16110319PubMed
1118197614
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions.
J Med Chem2008https://conductscience.org/library/papers/18197614PubMed
1234206076Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation.Molecules2021https://conductscience.org/library/papers/34206076PubMed
136137059Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.Science1983https://conductscience.org/library/papers/6137059PubMed
1437084598Synthesis of thieno[3,2-e]pyrrolo[1,2-a]pyrimidine derivatives and their precursors containing 2-aminothiophenes fragments as anticancer agents for therapy of pulmonary metastatic melanoma.Eur J Med Chem2023https://conductscience.org/library/papers/37084598PubMed
1522846796Design, synthesis, antimicrobial, anti-inflammatory and analgesic activity of novel isoxazolyl pyrimido[4,5-b]quinolines and isoxazolyl chromeno[2,3-d]pyrimidin-4-ones.Eur J Med Chem2012https://conductscience.org/library/papers/22846796PubMed
1638749115Synthesis and in vitro antitumor evaluation of new thieno[2,3-d]pyrimidine derivatives as EGFR and DHFR inhibitors.Bioorg Chem2024https://conductscience.org/library/papers/38749115PubMed
1740248243A green approach towards the on-water synthesis of multifunctional 3-amino/hydroxy thieno[3,2-c]pyrans.RSC Adv2025https://conductscience.org/library/papers/40248243PubMed
1824282643Solvent-Free Green and Efficient One-Pot Synthesis of Dihydropyrano[3,2-c]chromene Derivatives.ISRN Org Chem2013https://conductscience.org/library/papers/24282643PubMed
1933538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
2011902585Multidrug resistance in cancer: role of ATP-dependent transporters.Nat Rev Cancer2002https://conductscience.org/library/papers/11902585PubMed

See all 38 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42017162

GET https://conductscience.org/api/papers/v1/42017162/references?page=2